INTRODUCTION {#sec1-1}
============

Exercise-induced bronchoconstriction (EIB) is a condition in which vigorous physical activity stimulates acute airway narrowing in people with airway hyper-reactivity.\[[@ref1]\] The prevalence of EIB in patients with asthma has been reported to range from 40% to 90%.\[[@ref2][@ref3]\] EIB is a well-recognized medical indication for the prophylactic use of β~2~ agonists, so that its documentation would appear to justify the need for prophylaxis with a β~2~ agonist before exercise. Exercise protocols based on the duration of work or achievement of a specific heart rate have been proposed as standards for diagnosing EIB.\[[@ref4]\] However, there are some limitations with respect to standardization of both the workload and environmental conditions of temperature and humidity.\[[@ref5]\] The eucapnic voluntary hyperpnea (EVH) test has been proposed as an alternative to exercise as a laboratory-based test to identify EIB.\[[@ref6]\] However, provocation with EVH requires dry gas mixture limiting its availability. Provocation with methacholine requires less expensive equipment that is easily portable. In this study, we aimed to assess the sensitivity of methacholine challenge test (MCT) to identify EIB in 59 subjects using cardiopulmonary exercise test (CPET) as gold standard.

MATERIALS AND METHODS {#sec1-2}
=====================

Subjects {#sec2-1}
--------

Fifty-nine subjects (body mass index \[BMI\] \<35) referring to Baqiyatallah Medical Center with signs and symptoms suggestive of asthma but without a firm diagnosis of asthma or an exclusion of the diagnosis of asthma (e.g., had an equivocal diagnosis of asthma or had been referred for further investigation of asthma-type symptoms) were included. Subjects had at least step 1 symptoms according to the National Asthma Education Prevention Program (NAEPPII) expert panel II (The NAEPPII Report updated its recommendations for the monitoring and treatment of asthma in February 1997), that is, a kind of asthma severity grading (symptoms ≤2 times/week; asymptomatic between exacerbations; exacerbations of only a few hours to a few days; and night time symptoms of ≤ 2 times/month).\[[@ref7]\] They were required to have a forced expiratory volume in 1 second (FEV1) ≥70% of the predicted value at the Screening Visit. Subjects were excluded from participating this study if they: Had any known other pulmonary disease; had smoked more than 1 cigarette/week within the past year or had a ≥10 pack year smoking history; had a respiratory tract infection within the previous 4 weeks; had been skin test positive to aeroallergens that were present in the environment during the time of enrollment and reported worsening of symptoms when exposed to these aeroallergens during the study; had been diagnosed at screening visit as definitively having asthma or not having asthma; had clinically significant abnormal chest X-ray or electrocardiogram; or had failed to observe washout of medications that would interfere with CPET.

### Spirometry {#sec3-1}

First, baseline spirometry was performed for all cases using a volume displacement spirometer according to the methods recommended by the American Thoracic Society.\[[@ref8]\] The FEV1, forced vital capacity (FVC), and FEV1/FVC were expressed as percentage of predicted.

### Methacholine challenge test {#sec3-2}

Then, challenge test with methacholine was performed for all of our subjects. Methacholine (Provocholine™, Methapharm, CA, USA) was delivered from a DeVilbiss Healthcare 100 DeVilbiss Drive Somerset, Pennsylvania, US by the dosimeter method. The concentrations were: 0.0312, 0.0625, 0.125, 0.25, 0.5, 1, 2, and 4 mg/mL. Each concentration required five inhalations from functional residual capacity to total lung capacity. Spirometry was performed within 3 min. The response to methacholine was expressed as the concentration required provoking a 20% fall in FEV1 from the prechallenge value (provocative dose 20).

Cardiopulmonary exercise test {#sec2-2}
-----------------------------

At the end, in all patients, a maximal, symptom-limited CPET was performed on a Collins CPX system (Warren E. Collins, Inc., Braintree, Massachusetts, USA). A ramped protocol was used with 2 min of initial, unloaded cycling, followed by a graded increase in load until exhaustion. The workload increase was arbitrarily chosen to give a maximal test in 10--12 min. During all studies, expired gases, oximetry, heart rate, heart rhythm, and blood pressure (BP) were monitored. Oxygen consumption (VO~2~) was calculated and expressed as a percentage of predicted. Arterial blood gases were obtained via a catheter inserted in the radial artery or by radial puncture. Samples were obtained at rest and throughout the exercise period. All studies were interpreted by an experienced pulmonologist (Prof. Mostafa Ghanei).

The contraindications to MCT are summarized as following:

### Absolute {#sec3-3}

Severe airflow limitation (FEV \< 50% predicted or \< 1 L)Heart attack (ischemic heart disease) or stroke in the last 3 monthsUncontrolled hypertension, systolic BP \>200, or diastolic BP \>100Known aortic aneurysm.

### Relative {#sec3-4}

Moderate airflow limitation (FEV \< 60% predicted or \< 1.5 L)Inability to perform acceptable quality spirometryPregnancyNursing mothersCurrent use of cholinesterase inhibitor medication (for myasthenia gravis).

Statistical analysis {#sec2-3}
--------------------

Data were analyzed using SPSS software (version 18 for Windows; SPSS Inc., Chicago, IL, USA). Continuous variables are expressed as mean ± standard error of mean. Comparison between groups was performed using Student\'s sample *t*-test for continuous variables. *P* \< 0.05 was considered statistically significant.

And also, the sensitivity and specificity of these tests were evaluated.

### Ethical approval {#sec3-5}

The study was performed according to the principles of the Declaration of Helsinki, and the study protocol was approved by the local ethics review committee of Baqiyatallah University of Medical Sciences.

RESULTS {#sec1-3}
=======

In this study, two pulmonary specialists were as consolers. The average ages in patients with positive and negative methacholine test were, respectively, 40.95 and 34.8 years (*P* = 0.028). The age ranges in patients with positive and negative methacholine tests were, respectively, between 13 and 57 and 28 and 45 years. In attention to *P* = 0.028, it is age-related test. The BMI of each person was calculated by measurement of height and weight of the patients based on the BMI = weight^2^/height formula. The mean BMI values in patients with positive and negative methacholine test were, respectively, 25.76 and 25.22 (*P* = 0.0635).

In basic spirometry performed on all patients, the measured mean FVC values in patients with positive and negative methacholine tests were, respectively, 3.79 mL and 4.99 L (*P* = 0.001).

Also, the mean percentage of FVC from the predicted value was equal to 85.7% in patients with positive methacholine test and 99.25% in patients with negative methacholine test (*P* = 0.020). The measured mean FEV1 values in basic spirometry testing in patients with positive and negative methacholine tests were, respectively, equal to 2.79 L and 4.06 L (*P* = 0.000). Also, the measured mean percentages of FEV1 of the predictive value in patients with positive and negative methacholine test were, respectively, equal to 79.65% and 104.13% (*P* = 0.001).

In performed CPET, the mean VO~2~ values in patients with positive and negative methacholine tests were, respectively, equal to 20.45 mL/kg/min and 28.69 mL/kg/min (*P* = 0.000). The mean percentages of VO~2~ in patients with positive and negative methacholine tests were, respectively, equal to 72.52% and 105.32% (*P* = 0.000).

The mean VEVO~2~ (ventilatory equivalent for oxygen) values in patients with positive and negative methacholine tests were, respectively, equal to 38.75 and 37.44 (*P* = 0.525). The mean VEVCO~2~ (ventilatory equivalent for carbon dioxide) values in patients with positive and negative methacholine tests were, respectively, equal to 39.6 and 38.22 (*P* = 0.590). The anaerobic threshold mean values in patients with positive and negative methacholine tests were, respectively, equal to 29.85 L/min and 33.44 L/min (*P* = 0.334). The maximum average rates in patients with positive and negative methacholine tests were, respectively, equal to 88.85 bpm and 89.25 bpm (*P* = 0.83). The mean O~2~ pulse values in patients with positive and negative methacholine tests were, respectively, equal to 84.26 mL/beat and 116.27 mL/beat (*P* = 0.000) \[[Figure 1](#F1){ref-type="fig"}\].

![O~2~ pulse in two groups of negative and positive methacholine challenge tests](ACA-18-479-g001){#F1}

The mean heart rate reserve values measured in patients with positive and negative methacholine tests were, respectively, equal to 19.25 bpm and 20.11 bpm (*P* = 0.777). The VEMAX (MAX minute ventilatin) mean values in patients with positive and negative methacholine tests were, respectively, equal to 69.16 L/min and 80.66 L/min (*P* = 0.039) \[[Figure 2](#F2){ref-type="fig"}\].

![Ventilator equivalent max index in two groups of negative and positive methacholine challenge tests](ACA-18-479-g002){#F2}

The mean ventilator threshold (VT) values measured in patients with positive and negative methacholine tests were, respectively, equal to 1.63 L and 2.11 L (*P* = 0.021). The mean percentage values of VT in patients with positive and negative methacholine tests were, respectively, equal to 87.5% and 87.11% (*P* = 0.968). The mean maximum RR values in patients with positive and negative methacholine tests were, respectively, equal to 38.85 and 46.78 (*P* = 0.026) \[[Figure 3](#F3){ref-type="fig"}\].

![Respiratory rate peak in two groups of methacholine challenging test positive or negative](ACA-18-479-g003){#F3}

The mean respiratory reserve volume in patients with positive and negative methacholine tests were, respectively, equal to 28.5 and 26.33 (*P* = 0.798). The mean ETCO~2~ values in patients with positive and negative methacholine tests were, respectively, equal to 33.38 mmHg and 37.18 mmHg (*P* = 0.008). The mean ETO~2~ values in patients with positive and negative methacholine tests were, respectively, equal to 93.79 mmHg and 95.811 mmHg (*P* = 0.151).

The mean VD.VT values at rest in patients with positive and negative methacholine tests were, respectively, equal to 25.97 and 22.35 (*P* = 0.818). The mean maximum VD.VT values in patients with positive and negative methacholine tests were, respectively, equal to 37.35 and 38.92 (*P* = 0.002).

The mean respiratory quotient values in patients with positive and negative methacholine tests were, respectively, equal to 1.14 and 1.18 (*P* = 0.246). The mean oxygen saturation rates at rest in patients with positive and negative methacholine tests were, respectively, equal to 97.4% and 98% (*P* = 0.068). The mean oxygen saturation rates during the maximum activity test in patients with positive and negative methacholine tests were, respectively, equal to 96.55% and 96.75% (*P* = 0.626). All values of CPET were shown in [Table 1](#T1){ref-type="table"}.

###### 

Cardiopulmonary exercise test result based on two groups of positive and negative MCT

                        MCT        *n*   Mean        SD          *P*
  --------------------- ---------- ----- ----------- ----------- -------
  Age (years)           Positive   20    40.95       10.913      0.028
                        Negative   10    34.80       5.653       
  BMI (m^2^/kg)         Positive   20    25.7626     4.24861     0.635
                        Negative   10    25.2255     1.87595     
  FVC (L)               Positive   20    3.7970      0.78366     0.001
                        Negative   8     4.9963      0.64283     
  FVC.P (%)             Positive   20    85.70       12.798      0.020
                        Negative   8     99.25       13.957      
  FEV1 (L)              Positive   20    2.7965      0.70132     0.000
                        Negative   8     4.0650      0.63146     
  FEV1.P (%)            Positive   20    79.65       14.496      0.001
                        Negative   8     104.13      18.833      
  VO~2~ (mL/min)        Positive   20    20.455000   4.8550001   0.000
                        Negative   9     28.697778   4.3969358   
  VO~2~P.H.P (mL/min)   Positive   20    72.5205     12.60739    0.000
                        Negative   9     105.3216    16.93725    
  VEVO~2~               Positive   20    38.75       5.056       0.525
                        Negative   9     37.44       5.053       
  VEVCO~2~              Positive   20    39.60       6.508       0.590
                        Negative   9     38.22       5.740       
  AT.P (mL/min/kg)      Positive   20    29.85       9.252       0.334
                        Negative   9     33.44       8.734       
  PEAKHR.P (%)          Positive   20    88.85       3.843       0.830
                        Negative   8     89.25       5.651       
  O~2~ pulse (%)        Positive   20    84.2607     14.31402    0.000
                        Negative   9     116.2786    9.73503     
  HRR.M (mL)            Positive   20    19.25       6.742       0.777
                        Negative   9     20.11       9.089       
  VEMAX.P (L/min)       Positive   20    69.160      19.4218     0.039
                        Negative   9     80.667      16.4393     
  VT.M (mL)             Positive   20    1.636       0.378       0.021
                        Negative   9     2.114       0.672       
  VT.P.P (%)            Positive   20    87.50       21.414      0.968
                        Negative   9     87.11       30.056      
  RR.PEAK               Positive   20    38.85       8.580       0.026
                        Negative   9     46.78       7.981       
  BR (L)                Positive   20    28.50       22.322      0.798
                        Negative   9     26.33       16.800      
  ETCO~2~.PE (mmHg)     Positive   20    37.180000   2.5879478   0.008
                        Negative   9     33.388889   4.5892386   
  ETO~2~.PEA (mmHg)     Positive   20    93.795      2.9422      0.151
                        Negative   9     95.811      4.2899      
  VD.VT\@RE             Positive   20    153.35      25.974      0.818
                        Negative   9     155.67      22.136      
  VD.VT\@PE             Positive   20    133.65      37.359      0.002
                        Negative   9     80.22       38.929      
  RQ                    Positive   20    1.143500    0.0855493   0.246
                        Negative   9     1.183333    0.0790569   
  O~2~ SAT.R (%)        Positive   20    97.40       0.754       0.068
                        Negative   8     98.00       0.756       
                                                                 
  O~2~ SAT.P (%)        Positive   20    96.55       0.887       0.626
                        Negative   8     96.75       1.165       

BMI: Body mass index, FVC: Forced vital capacity, FEV1: Forced expiratory volume in 1 second, FVC.P: Forced vital capacity predicted, FEV1.P: Forced expiratory volume in 1 second predicted, VO~2~: Volume of oxygen consumption, VO~2~ P.H.P: Pulmonary oxygen uptake high pressure, VEVO~2~: Ventilator equivalent/ventilation per unitary change in oxygen consumption, VEVCO~2~: Ventilator equivalent/ventilation per unitary dioxide carbon production, VT.P.P: Ventilator threshold peak predicted, PEAKHR.P: Peak heart rate predicted, O~2~ pulse: Pulse oximetry, HRR.M: Heart rate reserved mean, VEMAX.P: Maximum ventilation during exercise predicted, VT.M: Ventilator threshold, mean, VT.P.P: Tidal volume peak predicted, RRPEAK: The peak of respiratory rate, BR: Breathing reserve, ETCO~2~.PE: Partial pressure of carbon dioxide, ETO~2~.PEA: Partial pressure of end tidal oxygen, VD.VT: Volume of dead space, RQ: Respiratory quotient, O~2~ SAT: O~2~ saturation, MCT: Methacholine challenging test, SD: Standard deviation

MCT has high false negative (low sensitivity) and low false positive but CPET has low false negative (high specificity) with moderate sensitivity.

DISCUSSION {#sec1-4}
==========

One of the indications for use of the cardiorespiratory exercise test is to examine the patient with dyspnea after activity. Numerous tests have been suggested to examine and study this group of patients, but all of them faced with some limitations. The CPET has been recognized as a complete test that evaluates various parameters during rest and activity. Evaluation of patients with exercise-induced dyspnea by this test can provide an appropriate assessment of the conditions of the patient\'s body different systems. This test has been already used in many clinical situations, including assessments before or after heart surgeries and evaluation of patients with interstitial lung disease.

No study has been performed so far aiming at comparing the CPET parameters in patients with different responses to methacholine test. We first studied and compared the CPET parameters in both groups of patients with positive and negative methacholine test and came to the conclusion that the positive response to the methacholine test can be the sign of a poor response of lung to the activity. In other words, it may be possible to overcome the symptoms of patients with bronchoconstriction by strengthening the lung response to the exercise.

The study results show that the VO~2~ rate in positive methacholine group is significantly lower compared to the normal group, which is mostly due to inadequate pulmonary responses to the exercise. This becomes clear by lower minute ventilation and respiratory rates that despite using adequate pulmonary reserve has failed to create adequate minute ventilation. However, a part of such a difference can be at least attributed to the age difference between the two groups.

We showed in our study that despite the VEVCO~2~ value\'s closeness in both groups, the levels of ETCO~2~ in positive methacholine group was higher, which reflects the inadequacy of the lungs to excrete CO~2~ that confirms the increased dead space ventilation. This is confirmed with significantly increased VD at peak exercising in positive methacholine group compared to the control group.

In our study, the O~2~ pulse in the positive methacholine group showed a significant decrease compared to the control group that its explanation seems to be difficult due to the instability of CPET findings in patients and controls. However, the increase in dead space ventilation in these patients could cause reduced cardiac output through increased dynamic hyperinflation, thereby leading to the drop in O~2~ pulse stroke volume. The main reason for the decline in O~2~ pulse is related to decline in stroke volume. However, any reason that leads to disruption in the rate of oxygen uptake by the tissues, including, musculoskeletal diseases, can cause a decline in the O~2~ pulse, which is not true regarding our patients.

In a study, Sill *et al*.\[[@ref9]\] compared the CPET findings in 105 patients with exercise-induced dyspnea with 69 normal volunteers and observed that the use of CPET in patients with exercise-induced dyspnea causes the increased specificity and the reduced diagnosis sensitivity. They stated that the CPET has not the required sensitivity in diagnosis of mild illness in young people.

In another study on 50 patients that the cause of their dyspnea had not detected by routine diagnostic methods, Martinez *et al*.\[[@ref10]\] used the CPET results. They observed that people with normal CPET had higher VO~2~ max and O~2~ pulse than those with diagnosis of heart disease, de-conditioning, or hyper-active airway disease. They stated that the CPET is useful for the diagnosis of heart and lung diseases, but has not the required sensitivity to differentiate the heart disease from de-conditioning cases.

There are some limitations in our study:

First, given the small sample size in our study, making definitive conclusions seems to be a little difficult and further studies with larger sample size are needed in the futureSecond, identifying and selecting the patients with dyspnea after exercise is so difficult and there are a lot of conflicts regarding the available tests for diagnosis. Therefore, our study may be affected by selection bias, and the results might have been somewhat distorted.

Finally, we conclude that pulmonary response to exercise in patients with the positive methacholine test is insufficient. The dead space ventilation in these patients has increased. Also, dynamic hyperinflation in patients with positive methacholine test causes the reduced stroke volume and O~2~ pulse in these patients.\[[@ref11]\]
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